Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

Discover strategies to overcome variability and optimize cryopreservation for scalable cell therapy development

The cell therapy landscape is evolving rapidly, and ensuring the scalability and manufacturability of therapies depends on reliable, standardized leukapheresis materials. Variability in starting material, logistical complexities, and site qualification challenges can hinder progress and increase costs. This webinar brings together leading industry experts to discuss how advancements in cryopreservation and integrated supply chain solutions are paving the way for the next generation of cell therapies.

Streamline your path to cell therapy success

Watch this on-demand roundtable webinar to gain actionable insights from experienced professionals in cell therapy development, cryopreservation innovation, and supply chain optimization. Whether you’re preparing to scale up your operations or seeking to enhance consistency across your manufacturing sites, this discussion provides essential knowledge to support your journey.

Watch this webinar for:

  • An understanding of how variability in leukapheresis materials impacts manufacturability and scalability in cell therapy.
  • The latest advancements in cryopreservation processes that enhance standardization across collection and manufacturing sites.
  • Proven strategies to overcome site qualification challenges and navigate site-to-site variability.
  • An overview of the critical role of an integrated supply chain in enabling seamless transport of cryopreserved materials.
  • Insights from industry experts on scaling cell therapy programs from clinical to commercial stages.